| Name | Title | Contact Details |
|---|---|---|
Christopher Blanchette |
Vice President and Head, Clinical Development and Outcomes Research, NNI | Profile |
John McDonald |
Corporate Vice President, Global R&D Business Development | Profile |
Jill Branca Priselac |
VP, R&D Business Development | Profile |
Benjamin Soule |
Senior Medical Director, NASH - Clinical Development and Research, NNI | Profile |
Rahul Ganguly |
Vice President, Clinical Development & Outcomes Research | Profile |
BALT is a world leader in the design and manufacture of interventional neuroradiology devices to treat neurovascular pathologies (strokes, aneurysms, AVMs).
Tweed and our sister company Tweed Farms are wholly owned subsidiaries of Tweed Marijuana Inc., traded on the TSX Venture Exchange as TWD. We are a Canadian company licensed under the Marihuana for Medical Purposes Regulations. We strive to supply a wide selection of marijuana, as diverse as the patients who trust us with their patronage.
Umoja is developing a new approach to cancer therapy that retools a patient`s immune system in vivo, enhancing the body`s natural capacity to fight cancer. We envision a world where all patients with cancer have access to the most advanced immunotherapies and are free from the burdens of traditional cancer therapies.
Advance Pharmacy Services , WV is a Charleston, WV-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
BioVectra Inc. is a Charlottetown, PE-based company in the Healthcare, Pharmaceuticals, and Biotech sector.